Short answer
Zymeworks Inc. (ZYME) filed an 8-K current report with the SEC on September 23, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 2.03 (Creation of a Direct Financial Obligation), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Material agreement relates to a Note Purchase Agreement and Guaranty and Security Agreement.
Zymeworks Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Material agreement relates to a Note Purchase Agreement and Guaranty and Security Agreement
- Incorporated documents contain the operative financing terms and security provisions for investor review
Item 7.01 · Regulation FD Disclosure
- Broad forward-looking disclosure covering merger, financing, milestone payments, royalties, R&D investment, and strategic opportunities
- Investor value depends on successful realization of merger benefits and financing-related flexibility
- Royalty and milestone upside tied to YUPELRI® sales and TRELEGY® performance
- Key risks include clinical failures, regulatory delays, commercialization risk for zanidatamab, and missed collaboration milestones
- Management provides no commitment to update projections for future events or new information
Item EX-99.1 · Exhibit EX-99.1
- Acquisition of Theravance Biopharma completed, making Theravance part of Zymeworks
- Strategic shift toward diversified revenue from commercial assets, royalties, and internal R&D
- YUPELRI, TRELEGY royalty interests, Ziihera, and pasritamig highlighted as portfolio assets
- Investor conference call scheduled September 28 at 8:30 a.m. ET for final transaction details
- Key risks include financing, integration benefits, product approvals, and achievement of anticipated milestones
Other items in this filing:
- Item 2.01: Completion of Acquisition or Disposition of Assets
- Item 2.03: Creation of a Direct Financial Obligation
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Zymeworks Inc. 8-K filings
Get the next ZYME 8-K as it lands
Follow ZYME for push alerts, or ask the research agent what this filing means.